Geriatric Medication Safety Symposium
Geriatric Medication Safety Symposium
批准号:
10456818
负责人:
Rajender R Aparasu
金额:
$5.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-08-01 至 2026-07-31
关键词:
AdministratorAdverse drug eventAgingAreaBedsCOVID-19 pandemicCaringChronicClinicCollaborationsComplexDental SchoolsDevelopmentDiseaseDrug InteractionsDrug PrescriptionsDrug usageEducational TechnologyEducational workshopElderlyEventFundingGoalsGrantHealthHealth ExpendituresHealth OccupationsHealth ProfessionalHealthcareHospitalizationHospitalsIncidenceInstitutionJointsJournalsKnowledgeLeadMedicalMedical Care CostsMedical centerMedication ErrorsMonitorMorbidity - disease rateNamesNursesNursing SchoolsOnline SystemsPatient CarePatientsPeer ReviewPersonsPharmaceutical PreparationsPharmacistsPharmacy SchoolsPharmacy facilityPhysiciansPoliciesPolypharmacyPreventionProcessProviderPublicationsPublishingResearchResearch PersonnelRiskScientistSeasonsStudentsTexasTreatment FailureUniversitiesage relatedbody systemcollegeevidence baseexperiencehigh riskhospital readmissionimprovedinpatient servicelive streammedical schoolsmedication safetymeetingsmembermortalityoff-label drugopioid abuseopioid useoutreachpatient safetypharmacokinetics and pharmacodynamicsposterssocialsymposiumtoolvirtualwebinar
中文摘要
摘要
与药物相关的发病率和死亡率是老年人的一个重大健康问题,
易受药物相关问题的影响。安全用药实践需要协调努力,
在用药过程中的供应商和患者。老年人与药物有关的问题范围从
从开高风险药物到老年人滥用处方药。减少用药
错误和改善用药安全是国家的主要优先事项。因此,我们的目标是主办
在世界上最大的医疗综合体,德克萨斯医疗中心举行的老年药物安全研讨会
(TMC),每年宣传和实施老年人用药安全的循证方法,
提高老年护理质量。休斯顿大学药学院与
与德克萨斯大学麦戈文医学院组织了休斯顿药物安全研讨会
在过去的三年里,专注于药物安全问题的各个方面,如高风险药物,
处方级联,并通过国家认可的专家的演讲取消处方。平均
每年有151个不同的卫生专业参加研讨会,以丰富他们的实践和研究,
药物安全。此外,研讨会还包括研究讲台和海报,
同行评审期刊我们正在申请五年的资金,以举办老年药物安全
研讨会,继续我们成功的努力,传播关键的药物安全问题,
实践、研究和政策。本次年度研讨会将:(一)提供一个良好的跨专业教育
为从业人员和研究人员举办论坛,讨论老年人循证用药安全方法;
(ii)在病人护理和药物安全研究方面加强合作,以获得最佳做法;
通过网络研讨会和出版物在全国范围内传播研讨会的知识和成果。该提案
包括由选定TMC机构的代表组成的每月规划委员会会议,
在TMC组织为期两天的研讨会,有超过20,000名医疗保健专业人员参加。的
研讨会包括四个全体会议,讲台和海报会议,实践/研究研讨会,
在五年内提供基于网络的内容和整合虚拟内容,以扩大覆盖面。的
即将举行的研讨会的重点领域包括COVID-19大流行期间的标签外药物使用,药物
负担,更安全的阿片类药物使用,药物不良事件,显著的药物相互作用,过渡期间的药物安全性
护理和住院治疗中的药物安全。目标受众包括医生,护士,药剂师,
学生,居民,研究员,研究人员和其他人。除此之外,还将创建教育和媒体工具,
在社会和行政药学杂志上发表论文。总的来说,老年人
药物安全研讨会将提供一个独特的跨专业教育和研究论坛,
医生和研究人员,使药物的做法更安全的老年人在TMC和超越。
英文摘要
ABSTRACT
Medication-related morbidity and mortality are a significant health concern in older adults, who are highly
susceptible to medication-related problems. Safe medication use practices require coordinated efforts by
providers and patients in the medication use process. Medication-related problems in older adults range from
prescribing of high-risk medications to misuse of prescribed medications by older adults. Reducing medication
errors and improving medication safety are major national priorities. Therefore, our objective is to host the
Geriatric Medication Safety Symposium in the largest medical complex in the world, the Texas Medical Center
(TMC), annually to disseminate and implement the evidence-based approaches for medication safety in older
adults to improve the quality of geriatric care. The University of Houston College of Pharmacy in collaboration
with the University of Texas McGovern Medical School organized the Houston Medication Safety Symposium
for the past three years focusing on various aspects of medication safety issues such high-risk medications,
prescribing cascades, and deprescribing with presentations from nationally recognized experts. An average of
151 diverse health professions participated in the symposium each year to enrich their practice and research on
medication safety. In addition, the symposium included research podiums and posters that were published in a
peer-reviewed journal. We are requesting five years of funding to host the Geriatric Medication Safety
Symposium to continue our successful efforts to disseminate critical medication safety issues with respect to
practice, research, and policy. This annual symposium will: (i) Provide an excellent interprofessional educational
forum for practitioners and researchers to discuss evidence-based medication safety approaches in older adults;
(ii) Increase collaborations for best practices in patient care and medication safety research; and (iii) Disseminate
the knowledge and findings from the symposium nationally through webinars and publications. The proposal
includes monthly planning committee meetings from representatives of selected TMC institutions to plan and
organize the two-day symposium in the TMC, with a reach of over 20,000 healthcare professionals. The
symposium includes four plenary sessions, podium and poster sessions, and practice/research workshops, with
web-based content delivery and integration of virtual content over five years to allow for greater reach. The
areas of focus for the upcoming symposiums include off-label drug use during the COVID-19 pandemic, drug
burden, safer opioid use, adverse drug events, significant drug interactions, drug safety during transitions of
care, and medication safety in inpatient care. The target audience includes physicians, nurses, pharmacists,
students, residents, fellows, researchers, and others. Educational and media tools will be created in addition to
publishing the proceedings in the Research in Social and Administrative Pharmacy journal. Overall, the Geriatric
Medication Safety Symposium will provide a unique interprofessional educational and research forum for
practitioners and researchers to make medication practices safer for older adults in the TMC and beyond.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Deprescribing of Disease Modifying Agents in Older Adults with Multiple Sclerosis
-
批准号:10718559
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2023
-
负责人:Rajender R Aparasu
-
依托单位:
Oral Adherence Trajectories Of Disease Modifying Agents And Associated Relapse Rates Among Patients With Multiple Sclerosis
-
批准号:10434699
-
项目类别:
-
资助金额:$2.58万
-
财政年份:2021
-
负责人:Rajender R Aparasu
-
依托单位:
Geriatric Medication Safety Symposium
-
批准号:10237632
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2021
-
负责人:Rajender R Aparasu
-
依托单位:
Geriatric Medication Safety Symposium
-
批准号:10669108
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2021
-
负责人:Rajender R Aparasu
-
依托单位:
Oral Adherence Trajectories Of Disease Modifying Agents And Associated Relapse Rates Among Patients With Multiple Sclerosis
-
批准号:10287874
-
项目类别:
-
资助金额:$7.42万
-
财政年份:2021
-
负责人:Rajender R Aparasu
-
依托单位:
Impact of Prescribing Cascade and Associated Drug Interaction in Alzheimer's Disease
-
批准号:10212709
-
项目类别:
-
资助金额:$44.99万
-
财政年份:2020
-
负责人:Rajender R Aparasu
-
依托单位:
Anticholinergics and Cognitive Decline in the Elderly with Depression
-
批准号:8544461
-
项目类别:
-
资助金额:$21.74万
-
财政年份:2012
-
负责人:Rajender R Aparasu
-
依托单位:
Anticholinergics and Cognitive Decline in the Elderly with Depression
-
批准号:8708817
-
项目类别:
-
资助金额:$21.51万
-
财政年份:2012
-
负责人:Rajender R Aparasu
-
依托单位:
Anticholinergics and Cognitive Decline in the Elderly with Depression
-
批准号:8439123
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2012
-
负责人:Rajender R Aparasu
-
依托单位:
Impact of Atypical Antipsychotic Use on Health Care Utilization in the Elderly
-
批准号:7661416
-
项目类别:
-
资助金额:$8.3万
-
财政年份:2009
-
负责人:Rajender R Aparasu
-
依托单位:
EVALUATION OF INAPPROPRIATE PSYCHOTROPIC USE IN ELDERLY
-
批准号:6200738
-
项目类别:
-
资助金额:$6.92万
-
财政年份:2000
-
负责人:Rajender R Aparasu
-
依托单位:
海外基金